Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation: A scintigraphic/pathological study

Circulation

Volumn 94, Issue 5, 1996, Pages 1010-1017

  Medrano, Rafael ^a   Lowry, Richard W ^a   Young, James B ^a   Weilbaecher, Donald G ^a   Michael, Lloyd H ^a   Afridi, Imran ^a   He, Zuo Xiang ^a   Mahmarian, John J ^a   Verani, Mario S ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

99mTc; myocardium; transplantation

Indexed keywords

TECHNETIUM 99M;

ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HEART MUSCLE CELL; HEART SCINTISCANNING; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; ISOTOPE LABELING; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING;

EID: 0029813487     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.5.1010     Document Type: Article

References (54)

1. Braunwald E, Rutherford JD. Reversible left ventricular dysfunction: evidence for the 'hibernating myocardium.' J Am Coll Cardiol. 1986; 8:1467-1470.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989; 117:211-213.
3. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986; 314:884-888.
4. Brunken RC, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol. 1987;10:557-567.
5. Tamaki N, Ohtani H, Yamashita K, Magata Y, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18 deoxyglucose. J Nucl Med. 1991;32:673-678.
6. Iskandrian AS, Hakki A, Kane SA, Goel IP, Mundth ED, Hakki AH, Segal BL. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol. 1983;51:1312-1316.
7. Cloninger KG, DePuey EG, Garcia EV, Roubin GS, Robbins WL, Nody A, DePasquale EE, Berger HJ. Incomplete redistribution in delayed thallium-201 single photon emission computed tomographic (SPECT) images: an overestimation of myocardial scarring. J Am Coll Cardiol. 1988;12:955-963.
8. Kiat H, Berman DS, Maddahi J, De Yang L, Train K, Rozanski A, Freidman J. Late reversibility of tomographic myocardial thallium- 201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol. 1988;12:1456-1463.
9. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990;323:141-146.
10. Tamaki N, Ohtani H, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J. Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med. 1990;31:1617-1623.
11. Rocco TP, Dilsizian V, McKusick KA, Fischman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest 'reinjection' imaging for the detection of viable myocardium. Am J Cardiol. 1990;66:158-163.
12. 18F-fluorodeoxyglucose. Circulation. 1991;83:26-37.
13. Ohtani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T, Konishi J. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery grafting. Am J Cardiol. 1990;66:394-399.
14. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, Boucher CA, Picard M, Holman BL, Fridrich R. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med. 1989;30:301-311.
15. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation. 1988;77:491-498.
16. Maublant JC, Gachon P, Moins N. Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells. J Nucl Med. 1988;29:48-54.
17. Sinusas AJ, Watson DD, Cannon JM Jr, Beller GA. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol. 1989;14:1785-1793.
18. 201Tl to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation. 1990;81:289-296.
19. Freeman I, Grunwald AM, Hoory S, Bodenheimer MM. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med. 1991;32:292-298.
20. Sinusas AJ, Trautman KA, Bergin JD, Watson DD, Ruiz M, Smith WH, Beller GA. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation. 1990;82:1424-1437.
21. Li Q-S, Frank TL, Franceschi D, Wagner HN Jr, Becker LC. Technetium-99m methoxyisobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogs. J Nucl Med. 1988; 29:1539-1548.
22. Beanlands RS, Dawood F, Wen WH, McLaughlin PR, Butany J, D'Amati G, Liu PP. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation. 1990;82:1802-1814.
23. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile)technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation. 1990;82:1826-1838.
24. 201Tl in the presence of a severe coronary stenosis. Circulation. 1994;89:2332-2341.
25. Taillefer R, Primeau M, Costi P, Lambert R, Leveille J, Latour Y. Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hour) and relaxed (3-hour) postexercise images. J Nucl Med. 1991;32: 1961-1965.
26. 18F]fluorodeoxyglucose. Circulation. 1994;89:578-587.
27. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME Jr, Stevenson LS. 24th Bethesda Conference: cardiac transplantation. Task Force 3: Recipient Guidelines/Prioritization. J Am Coll Cardiol. 1993;22:21-31.
28. Quiñones MA, Waggoner AD, Reduto LA, Nelson JG. Young JB, Winters WL Jr, Ribeiro LG, Miller RR. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation. 1981;64:744-753.
29. Hackel DB, Reimer KA, Ideker RE, Mikat EM, Haitwell TD, Parker CB, Braunwald EB, Buja M, Gold HK, Jaffe AS, et al. Comparison of enzymatic and anatomical estimates of myocardial infarct size in man. Circulation, 1984;70:824-835.
30. Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B, Bolli R. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol. 1988;12:1573-1581.
31. DeCoster PM, Wijns W, Cauwe F, Robert A, Beckers C, Melin JA. Area at risk determination by technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile in experimental reperfused myocardial infarction. Circulation. 1990;82:2151-2162.
32. Gibbons RJ, Verani MS, Behrenbeck T, Pellikka PA, O'Connor MK, Mahmarian JJ, Chesebro JH, Wackers FJ. Feasibility of tomographic Tc-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation. 1989;80:1277-1286.
33. Christian TF, Behrenbeck T, Pellikka PA, Huber KC, Chesebro JH, Gibbons RJ. Mismatch of left ventricular function and infarct size demonstrated by technetium-99m-isonitrile imaging after reperfusion therapy for acute myocardial infarction: identification of myocardial stunning and hyperkinesia. J Am Coll Cardiol. 1990;16:1632-1638.
34. Christian TF, Behrenbeck T, Gersh BJ, Gibbons RJ. Relation of left ventricular volume and function over one year after acute myocardial infarction to infarct size determined by technetium-99m sestamibi. Am J Cardiol. 1991;68:21-26.
35. Santoro GM, Bisi G, Sciagra R, Leoncini M, Fazzini PF, Meldolisi V. Single photon emission computed tomography with technetium-99m-hexakis-2-methoxyisobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery. J Am Coll Cardiol. 1990;15:301-314.
36. Pellikka PA, Behrenbeck T, Verani MS, Mahmarian JJ, Wackers FJTh, Gibbons FJ. Serial changes in myocardial perfusion using tomographic technetium-99m-hexakis-2-methoxy-2-methylpropylisonitrile imaging following reperfusion therapy of myocardial infarction. J Nucl Med. 1990;31:1269-1275.
37. Christian TF, Gibbons RJ, Gersh BJ. Effect of infarct location on myocardial salvage assessed by technetium-99m-isonitrile. J Am Coll Cardiol. 1991;17:1303-1308.
38. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685-691.
39. 99mTc-sestamibi defect size. Circulation. 1993;88:2224-2234.
40. Mahmarian JJ, Pratt CM, Borges-Neto S, Cashion WR, Roberts R, Verani MS. Quantification of infarct size by thallium-201 single-photon emission computed tomography during acute myocardial infarction in man: comparison with enzymatic estimates. Circulation. 1988;78:831-839.
41. Tamaki S, Nakajima H, Murakami T, Yui Y, Kambara H, Kadota K, Yoshida A, Kawai C, Tamaki N, Mukai T, Ishii Y, Torizuka K. Estimation of infarct size by myocardial emission computed tomography with thallium-201 and its relation to creatine kinase-MB release after myocardial infarction in man. Circulation. 1982;66:994-1001.
42. Wackers FJ, Becker AE, Samson G, Sokole EB, van der Schoot JB, Vet AJ, Lie KI, Durrer D, Wellens H. Location and size of acute transmural myocardial infarction estimated from thallium-201 scintiscans: a clinicopathological study. Circulation. 1977;56:72-78.
43. Delbeke D, Lorenz CH, Votaw JR, Silveira ST, Frist WH, Atkinson JB, Kessler RM, Sandler MP. Estimation of left ventricular mass and infarct size from nitrogen-13-ammonia PET images based on pathological examination of explanted human hearts. J Nucl Med. 1993; 34:826-833.
44. Sinusas AJ, Hardin NJ. Clements JP, Wackers FJ. Pathoanatomic correlates of regional ventricular wall motion assessed by equilibrium radionuclide angiocardiography: a postmortem correlation. Am J Cardiol. 1984;54:975-981.
45. Cabin HS, Clubb KS, Vita N, Zaret BL. Regional dysfunction by equilibrium radionuclide angiography: a clinicopathologic study evaluating the relation of degree of dysfunction to the presence and extent of myocardial infarction. J Am Coll Cardiol. 1987;10:743-747.
46. Beller GA. Radiopharmaceuticals in nuclear cardiology. In: Beller GA, ed. Clinical Nuclear Cardiology. Philadelphia, Pa: WB Saunders; 1995:37-81.
47. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med. 1992;33:505-511.
48. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation, 1993;82:1630-1641.
49. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radio-isotopic assessment of myocardial viability. J Nucl Med. 1992;33:1925-1930.
50. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M, Konishi Y, Hirata K, Ban T, Konishi J. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary bypass grafting. Am J Cardiol. 1989;64:860-865.
51. Altehoefer C, Kaiser HJ, Dörr R, Feinendegen C, Beilin I, Uebis R, Buell Y. Fluorine-18 deoxyglucose PET for the assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPECT: a comparative study in patients with coronary artery disease. Eur J Nucl Med. 1992;19:334-342.
52. 99mTc-sestamibi. Circulation. 1994;89: 252-261.
53. 201Tl activity in irreversible defects as a marker of myocardial viability: clinicopathological study. Circulation. 1995;91:1016-1021.
54. Dilsizian V, Quigg RJ, Shirani J, Lee J, Alavi K, Pick R, Bacharach SL. Histomorphologic validation of thallium reinjection and fluorodeoxyglucose PET for assessment of myocardial viability. Circulation. 1994;90(suppl I):I-314. Abstract.